Works matching IS 08909091 AND DT 2023 AND VI 37 AND IP 4

Results: 8
    1

    Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma.

    Published in:
    Oncology (08909091), 2023, v. 37, n. 4, p. 175
    By:
    • Catenacci, Daniel V. T.;
    • Yoon-Koo Kang;
    • Uronis, Hope E.;
    • Keun-Wook Lee;
    • Ng, Matthew C. H.;
    • Enzinger, Peter C.;
    • Se Hoon Park;
    • Gold, Philip J.;
    • Lacy, Jill;
    • Hochster, Howard S.;
    • Sang Cheul Oh;
    • Yeul Hong Kim;
    • Marrone, Kristen A.;
    • Kelly, Ronan J.;
    • Juergens, Rosalyn A.;
    • Jong Gwang Kim;
    • Alcindor, Thierry;
    • Sun Jin Sym;
    • Eun-Kee Song;
    • Cheng Ean Chee
    Publication type:
    Article
    2
    3
    4
    5
    6

    Burnout: Which Way Out?

    Published in:
    Oncology (08909091), 2023, v. 37, n. 4, p. 161
    By:
    • Vose, Julie M.
    Publication type:
    Article
    7

    EDITORS NOTE.

    Published in:
    Oncology (08909091), 2023, v. 37, n. 4, p. 160
    Publication type:
    Article
    8

    PUBLISHER'S NOTE.

    Published in:
    Oncology (08909091), 2023, v. 37, n. 4, p. 160
    Publication type:
    Article